PHI with House dust allergy
How does this condition affect your private health insurance?
Hausstauballergie, or dust mite allergy, is an immune system's hypersensitivity to proteins in the feces and body parts of microscopic house dust mites. These ubiquitous arachnids thrive in warm, humid indoor environments, commonly inhabiting bedding, carpets, and upholstery. Symptoms primarily include allergic rhinitis (sneezing, runny nose, nasal congestion, itchy nose), allergic conjunctivitis (itchy, watery eyes), and skin reactions. Critically, it can also trigger or exacerbate asthma, manifesting as coughing, wheezing, and shortness of breath. Management often involves environmental control, symptomatic medications, and in some cases, allergen-specific immunotherapy.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Hours to days, as long as exposure persists.
Duration of Illness (Lifetime)
Typically a chronic, lifelong condition, though symptom severity can fluctuate.
Cost of Treatment (Initial)
Approximately 100-300 EUR for initial consultation, diagnostic tests (e.g., skin prick test), and symptomatic medications.
Cost of Treatment (Lifetime)
Thousands to tens of thousands of EUR over a lifetime, including regular medications (e.g., 20-100 EUR/month), allergen avoidance measures, and potentially allergen-specific immunotherapy (e.g., 800-1500 EUR per year for 3-5 years).
Mortality Rate
Extremely low, near 0%. The allergy itself is not directly fatal, but severe, poorly managed asthma exacerbations, if triggered, carry a very low risk of mortality.
Risk of Secondary Damages
High (50-80%). Common secondary damages include chronic rhinitis, development or worsening of allergic asthma, chronic sinusitis, sleep disturbances, reduced quality of life, and exacerbation of atopic dermatitis.
Probability of Full Recovery
Low (under 10%) without intervention; moderate (50-70%) with successful, long-term allergen-specific immunotherapy leading to sustained remission.
Underlying Disease Risk
Moderate to high (50-80%). Often co-occurs with other atopic conditions such as allergic asthma, atopic dermatitis (eczema), and other environmental or food allergies.